Article
Non-invasive decision support for NSCLC treatment using PET/CT radiomics.
Nature communications - 16 Oct 2020
Mu Wei, Jiang Lei, Zhang JianYuan, Shi Yu, Gray Jhanelle E, Tunali Ilke, Gao Chao, Sun Yingying, Tian Jie, Zhao Xinming, Sun Xilin, Gillies Robert J, Schabath Matthew B
Abstract excerpt
Two major treatment strategies employed in non-small cell lung cancer, NSCLC, are tyrosine kinase inhibitors, TKIs, and immune checkpoint inhibitors, ICIs. The choice of strategy is based on heterogeneous biomarkers that can dynamically change during therapy. Thus, there is a compelling need to identify comprehensive biomarkers that can be used longitudinally to help guide therapy choice. Herein, we report a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
